Gut microbiota and ovarian diseases: a new therapeutic perspective

被引：0

作者：

Shan Ju ^{[1
]}

Zhen Yang Kang ^{[2
]}

Li Ya Yang ^{[3
]}

Yong Jun Xia ^{[3
]}

Yi Ming Guo ^{[1
]}

Sui Li ^{[2
]}

Hongli Yan ^{[3
]}

Ming Kang Qi ^{[1
]}

Hui Ping Wang ^{[4
]}

Lian Zhong ^{[2
]}

机构：

[1] University of Shanghai for Science and Technology,School of Health Science and Engineering, Shanghai Engineering Research Center of Food Microbiology

[2] Chinese Academy of Medical Sciences,Graduate School of Peking Union Medical College

[3] National Research Institute for Family Planning,NHC Key Laboratory of Reproductive Health Engineering Technology Research (NRIFP)

[4] Changhai hospital,undefined

[5] the Navy medical university,undefined

来源：

Journal of Ovarian Research | / 18卷 / 1期

关键词：

Gut microbiota; Premature ovarian insufficiency; Polycystic ovary syndrome; Ovarian tumors;

D O I：

10.1186/s13048-025-01684-5

中图分类号：

学科分类号：

摘要：

The gut microbiota is a complex community of microorganisms that inhabit the human gastrointestinal tract, helping to maintain the ecological balance of the body’s internal and external environments. Disruptions in the composition and diversity of gut microbiota, as well as changes in their metabolic functions, can link to the development and severity of conditions such as premature ovarian insufficiency, polycystic ovary syndrome, and ovarian tumors. This article thoroughly reviews recent research on the connection between gut microbiota and ovarian diseases, providing fresh perspectives on their prevention, pathogenesis, and treatment.

引用

共 50 条

[31] The gut microbiota: a new perspective on the toxicity of malachite green (MG)
Tongtong Li
Dongcan Tian
Zhenzhen Zhu
Weihua Jin
Shijin Wu
Huan Li
Applied Microbiology and Biotechnology, 2019, 103 : 9723 - 9737
[32] Gut microbiota in diabetic-linked polycystic ovarian syndrome: Mechanisms and therapeutic insights
Mehta, Prachi
Saha, Dipankar
Das, Abinash
Das, Bhrigu Kumar
TISSUE & CELL, 2025, 95
[33] Gut microbiota: a perspective of precision medicine in endocrine disorders
Rad, Salman Shirvani
Nikkhah, Amirabbas
Orvatinia, Mohammadmahdi
Ejtahed, Hanieh-Sadat
Sarhangi, Negar
Jamaldini, Seyed Hamid
Khodayari, Nazli
Meybodi, Hamid Reza Aghaei
Hasanzad, Mandana
JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2020, 19 (02) : 1827 - 1834
[34] Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota
Zhang, Hai-Yu
Tian, Jia-Xing
Lian, Feng-Mei
Li, Min
Liu, Wen-Ke
Zhen, Zhong
Liao, Jiang-Quan
Tong, Xiao-Lin
BIOMEDICINE & PHARMACOTHERAPY, 2021, 133
[35] Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases
Cammarota, Giovanni
Pecere, Silvia
Laniro, Gianluca
Masucci, Luca
Curro, Diego
DIGESTIVE DISEASES, 2016, 34 (03) : 279 - 285
[36] Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases
Biazzo, Manuele
Deidda, Gabriele
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
[37] Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
Eleonora Distrutti
Lorenzo Monaldi
Patrizia Ricci
Stefano Fiorucci
World Journal of Gastroenterology, 2016, 22 (07) : 2219 - 2241
[38] Gut microbiota and metabolic disease: from pathogenesis to new therapeutic strategies
Kang, Yongbo
Zhang, Xiaofang
Cai, Yue
Su, Junhong
Kong, Xiangyang
REVIEWS IN MEDICAL MICROBIOLOGY, 2016, 27 (04) : 141 - 152
[39] Gut microbiota and allergy/asthma: From pathogenesis to new therapeutic strategies
Kang, Y. B.
Cai, Y.
Zhang, H.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2017, 45 (03) : 305 - 309
[40] Gut Microbiota and Vascular Diseases: An Update
Wu, Jiaqi
Li, Yuxuan
Yang, Peipei
Fu, Jiantao
Wang, Yidong
CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2024, 9 (01)

← 1 2 3 4 5 →